Načítá se...
Minimax and admissible adaptive two-stage designs in phase II clinical trials
BACKGROUND: Simon’s two-stage design is the most widely implemented among multi-stage designs in phase II clinical trials to assess the activity of a new treatment in a single-arm study. In this two-stage design, the sample size from the second stage is fixed regardless of the number of responses ob...
Uloženo v:
| Vydáno v: | BMC Med Res Methodol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4969653/ https://ncbi.nlm.nih.gov/pubmed/27485595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12874-016-0194-3 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|